Patent 7153879 was granted and assigned to Bristol-Myers Squibb on December, 2006 by the United States Patent and Trademark Office.
There are provided in accordance with the present invention two crystalline polymorphs, designated Form A and Form B, respectively, as well as mixtures thereof, of an epothilone analog represented by the formula